↓ Skip to main content

Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032

Overview of attention for article published in Journal of Translational Medicine, July 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news
1 news outlet
patent
3 patents
googleplus
1 Google+ user

Readers on

mendeley
166 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032
Published in
Journal of Translational Medicine, July 2010
DOI 10.1186/1479-5876-8-67
Pubmed ID
Authors

Jill C Rubinstein, Mario Sznol, Anna C Pavlick, Stephan Ariyan, Elaine Cheng, Antonella Bacchiocchi, Harriet M Kluger, Deepak Narayan, Ruth Halaban

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 166 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
Hong Kong 1 <1%
Unknown 164 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 33 20%
Student > Ph. D. Student 27 16%
Student > Bachelor 27 16%
Student > Master 18 11%
Other 12 7%
Other 26 16%
Unknown 23 14%
Readers by discipline Count As %
Medicine and Dentistry 45 27%
Agricultural and Biological Sciences 39 23%
Biochemistry, Genetics and Molecular Biology 25 15%
Pharmacology, Toxicology and Pharmaceutical Science 6 4%
Immunology and Microbiology 4 2%
Other 19 11%
Unknown 28 17%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 20 September 2023.
All research outputs
#2,376,931
of 24,580,204 outputs
Outputs from Journal of Translational Medicine
#393
of 4,415 outputs
Outputs of similar age
#8,559
of 99,341 outputs
Outputs of similar age from Journal of Translational Medicine
#2
of 12 outputs
Altmetric has tracked 24,580,204 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,415 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.9. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 99,341 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 12 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.